Inventor
DIETRICH RANGO
DE30 patents
⚠️ This page may combine multiple inventors who share the name “DIETRICH RANGO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NYCOMED GMBH
9 patentsUS7951398B2May 31, 2011
Pharmaceutical preparation comprising an active dispersed on a matrix
NYCOMED GMBH50 citations97
US7951397B2May 31, 2011
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
NYCOMED GMBH13 citations92
US7794752B1Sep 14, 2010
Preparation and administration form comprising an acid-labile active compound
NYCOMED GMBH10 citations84
US7790198B2Sep 7, 2010
Preparation and administration form comprising an acid-labile active compound
NYCOMED GMBH8 citations84
US7785630B2Aug 31, 2010
Preparation and administration form comprising an acid-labile active compound
NYCOMED GMBH10 citations84
US7357943B2Apr 15, 2008
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
NYCOMED GMBH13 citations84
US7351723B2Apr 1, 2008
Freeze-dried pantoprazole preparation and pantoprazole injection
NYCOMED GMBH10 citations84
US7988999B2Aug 2, 2011
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
NYCOMED GMBH6 citations63
US7402321B2Jul 22, 2008
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
NYCOMED GMBH0 citations51
BYK GULDEN LOMBERG CHEM FAB
8 patentsUS6328993B1Dec 11, 2001
Oral administration form for an acid liable active proton pump inhibitor
BYK GULDEN LOMBERG CHEM FAB86 citations99
US6274173B1Aug 14, 2001
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
BYK GULDEN LOMBERG CHEM FAB107 citations99
US6132768AOct 17, 2000
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
BYK GULDEN LOMBERG CHEM FAB92 citations98
US5997903ADec 7, 1999
Oral-administration forms of a medicament containing pantoprazol
BYK GULDEN LOMBERG CHEM FAB103 citations97
US6383510B1May 7, 2002
Suppository form comprising an acid-labile active compound
BYK GULDEN LOMBERG CHEM FAB69 citations96
US6068856AMay 30, 2000
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
BYK GULDEN LOMBERG CHEM FAB54 citations96
US5945124AAug 31, 1999
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
BYK GULDEN LOMBERG CHEM FAB77 citations96
US6884437B2Apr 26, 2005
Administration form comprising an acid-labile active compound
BYK GULDEN LOMBERG CHEM FAB3 citations63
ALTANA PHARMA AG
6 patentsUS6569453B2May 27, 2003
Administration form comprising an acid-labile active compound
ALTANA PHARMA AG57 citations96
US7175854B2Feb 13, 2007
Pharmaceutical preparation comprising an active dispersed on a matrix
ALTANA PHARMA AG30 citations92
US7147869B2Dec 12, 2006
Rapidly disintegrating tablet comprising an acid-labile active ingredient
ALTANA PHARMA AG33 citations92
US6780881B2Aug 24, 2004
Freeze-dried pantoprazole preparation and pantoprazole injection
ALTANA PHARMA AG14 citations92
US7041313B1May 9, 2006
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
ALTANA PHARMA AG11 citations83
US6607742B2Aug 19, 2003
Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer
ALTANA PHARMA AG10 citations74
DIETRICH RANGO
4 patentsUSD620976SAug 3, 2010
Binder
DIETRICH RANGO22 citations92
US8431154B2Apr 30, 2013
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
DIETRICH RANGO5 citations82
US8465767B2Jun 18, 2013
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
DIETRICH RANGO0 citations50
US8758817B2Jun 24, 2014
Dosage form containing (S)-pantoprazole as active ingredient
DIETRICH RANGO0 citations44